======= DNAJC2 =======
== Gene Information ==
* **Official Symbol**: DNAJC2
* **Official Name**: DnaJ heat shock protein family (Hsp40) member C2
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=27000|27000]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q99543|Q99543]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=DNAJC2&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20DNAJC2|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/605502|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: N/A
* **UniProt Summary**: Acts both as a chaperone in the cytosol and as a chromatin regulator in the nucleus. When cytosolic, acts as a molecular chaperone: component of the ribosome-associated complex (RAC), a complex involved in folding or maintaining nascent polypeptides in a folding-competent state. In the RAC complex, stimulates the ATPase activity of the ribosome-associated pool of Hsp70-type chaperones HSPA14 that bind to the nascent polypeptide chain. When nuclear, mediates the switching from polycomb- repressed genes to an active state: specifically recruited at histone H2A ubiquitinated at 'Lys-119' (H2AK119ub), and promotes the displacement of the polycomb PRC1 complex from chromatin, thereby facilitating transcription activation. Specifically binds DNA sequence 5'-GTCAAGC-3'. {ECO:0000269|PubMed:15802566, ECO:0000269|PubMed:16002468, ECO:0000269|PubMed:21179169}.
|Myb DNA-binding|
|DnaJ|
|de novo cotranslational protein folding|
|ubiquitin modification-dependent histone binding|
|negative regulation of DNA biosynthetic process|
|de novo protein folding|
|Hsp70 protein binding|
|regulation of cellular response to heat|
|regulation of DNA biosynthetic process|
|negative regulation of DNA metabolic process|
|histone binding|
|DNA replication|
|protein folding|
|nuclear membrane|
|regulation of DNA metabolic process|
|chromatin binding|
|chromatin organization|
|regulation of cellular response to stress|
|chromosome organization|
|negative regulation of cellular macromolecule biosynthetic process|
|RNA binding|
|negative regulation of nucleobase-containing compound metabolic process|
|DNA binding|
|negative regulation of macromolecule biosynthetic process|
|regulation of response to stress|
|negative regulation of cellular biosynthetic process|
|positive regulation of transcription, DNA-templated|
|negative regulation of biosynthetic process|
|DNA-binding transcription factor activity, RNA polymerase II-specific|
|positive regulation of nucleic acid-templated transcription|
|positive regulation of RNA biosynthetic process|
|cellular macromolecule biosynthetic process|
|positive regulation of RNA metabolic process|
|macromolecule biosynthetic process|
|positive regulation of nucleobase-containing compound metabolic process|
|positive regulation of macromolecule biosynthetic process|
|positive regulation of cellular biosynthetic process|
|positive regulation of gene expression|
|positive regulation of biosynthetic process|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp89|Vemurafenib 6.6μM R02 exp89]]|-1.71|
|[[:results:exp66|BI-D1870 3.15μM R02 exp66]]|1.73|
|[[:results:exp25|Oligomycin-A 2μM R00 exp25]]|1.76|
|[[:results:exp498|Lead acetate 2000μM R08 exp498 no dilution day6]]|1.77|
|[[:results:exp264|Arsenate 40μM R06 exp264]]|1.96|
|[[:results:exp488|Hippuristanol 0.12μM R08 exp488]]|2.06|
|[[:results:exp38|Wortmannin 5μM R00 exp38]]|2.06|
|[[:results:exp71|KU-0063794 3.8μM R02 exp71]]|2.12|
|[[:results:exp70|INK128 0.2μM R02 exp70]]|2.2|
|[[:results:exp29|Rapamycin 1μM R00 exp29]]|2.24|
|[[:results:exp468|CB-5083 0.4μM R08 exp468]]|2.55|
|[[:results:exp30|Rapamycin 10μM R00 exp30]]|2.76|
|[[:results:exp504|MK2206 4μM R08 exp504]]|3.5|
^Gene^Correlation^
|[[:human genes:h:hspa14|HSPA14]]|0.598|
Global Fraction of Cell Lines Where Essential: 0/726
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/25|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/15|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/14|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/7|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 1351
* **Expression level (log2 read counts)**: 6.79
{{:chemogenomics:nalm6 dist.png?nolink |}}